home / stock / gntlf / gntlf news

GNTLF News and Press, Genetic Techs Ltd Aud From 05/03/23

Stock Information
Company Name: Genetic Techs Ltd Aud
Stock Symbol: GNTLF
Market: OTC
Website: gtglabs.com
Menu
GNTLF GNTLF Quote GNTLF Short GNTLF News GNTLF Articles GNTLF Message Board
Get GNTLF Alerts

News, Short Squeeze, Breakout and More Instantly...
GNTLF - Genetic Technologies Limited (GENE) Q3 2023 Earnings Call Transcript

2023-05-03 23:45:09 ET Genetic Technologies Limited (GENE) Q3 2023 Earnings Conference Call May 03, 2023 05:00 PM ET Company Participants Adrian Mulcahy - Investor Relations Simon Morriss - Chief Executive Officer Tony Di Pietro - Chief Financial Officer Co...
GNTLF - New Publication Validates geneType for Melanoma Risk Assessment

MELBOURNE, Australia, April 28, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) a global leader in genomics-based tests in health, wellness and serious disease is pleased to announce the publication of a research paper i...

GNTLF - Quarterly Business Update - March 2023

MELBOURNE, Australia, April 27, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, ”Company”, “GTG”), a global leader in guideline-driven genomics-based testing in health, wellness and serious diseases, releases its Appendix 4C and Quarterly b...

GNTLF - Publication Validates geneType Prostate Cancer Risk Test

MELBOURNE, Australia, April 19, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) a global leader in genomics-based tests in health, wellness and serious disease is pleased to announce the publication of a research paper i...
GNTLF - GeneType Multi-Risk Test now includes Melanoma, Pancreatic Cancer & Atrial Fibrillation

MELBOURNE, Australia, March 27, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) – a global leader in genomics-based tests in health, wellness and serious disease – is pleased to announce the US launch of th...

GNTLF - Back-to-back Studies Validate geneType Breast Cancer Risk Test

MELBOURNE, Australia, March 13, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce the publication of another research...

GNTLF - Genetic Technologies Limited (GENE) Q2 2023 Earnings Call Transcript

Genetic Technologies Limited (GENE) Q2 2023 Earnings Conference Call Feb 27, 2023, 05:00 PM ET Company Participants Adrian Mulcahy - Investor Relations Simon Morriss - CEO Tony Di Pietro – CFO Carl Stubbings - Chief Commercial Officer Conference Call P...
GNTLF - New Publication Highlights geneType's Ability to Detect Breast Cancer Earlier and Provide Data for Risk Stratification

MELBOURNE, Australia, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) – a global leader in genomics-based tests in health, wellness and serious disease – is pleased to announce the publication of a...

GNTLF - Genetic Technologies Announces Closing of $5 Million Registered Direct Offering

MELBOURNE, Australia, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, to...

GNTLF - Genetic Technologies to Launch Ground-breaking Comprehensive Risk Test for Breast & Ovarian Cancer

MELBOURNE, Australia, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is delighted to provide further update. The innovation ...
Previous 10 Next 10